Abamune-L Tablet contains Abacavir 600 mg and Lamivudine 300 mg, two NRTIs used together in HIV-1 combination therapy to inhibit reverse transcriptase and reduce viral replication.

Mechanism of Action

Both Abacavir and Lamivudine act as nucleoside reverse transcriptase inhibitors, blocking the enzyme required for viral DNA synthesis and inhibiting HIV replication. ([turn0search0], [turn0search2])

Dosage & Administration

Take one tablet once daily at the same time each day, with or without food. Do not split or crush the tablet. ([turn0search11])

Side Effects & Precautions

• Common: headache, fatigue, nausea, rash, fever.
• Serious: hypersensitivity reactions—HLA-B*5701 screening is recommended before initiating Abacavir. Use caution in pregnancy and avoid alcohol. Monitor hepatic function regularly.

Disclaimer

For product listing purposes only. This information is not a substitute for medical advice. Always follow healthcare provider instructions.